Active ingredientLaninamivirCat. No. P-L013-001CAS 203120-17-6Family · Pharmaceutical analytical standards
Laninamivir
A long-acting neuraminidase inhibitor antiviral, approved in Japan in 2010 to treat influenza A and B and in 2013 also to prevent it: it is given by inhalation. This family brings together the active ingredient and other impurities.
Did you know?It is inhaled as a prodrug, an inactive form that releases laninamivir: in experiments in mice the active molecule stayed in the lungs for a long time, hence its long duration of action.
Go to the active ingredient →Active ingredientLaninamivirCat. No. P-L013-001CAS 203120-17-6
ImpurityLaninamivir DioctanoateCat. No. P-L013-002CAS 1169517-07-0
ImpurityLaninamivir OctanoateCat. No. P-L013-003CAS 203120-46-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.